It was discovered before, that treatment of prostate cancer cells with paclitaxel and TRAIL resulted in greater processing of caspase-8, Bid, procaspase-9 and caspase-3, resulting in engagement of the mitochondrial pathway to apoptosis [49]. This evidence concerns the gene CASP3 and Familial prostate cancer.